


Acumen Pharmaceuticals
Biotechnology Research • Greater Boston, MA, United States • 51-100 Employees
Company overview
| Headquarters | Greater Boston, MA, United States |
| Phone number | +14342971000 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Therapeutics, Immunotherapy, Alzheimer'S Disease, Neurodegenerative Disease, Amyloid-Beta Oligomers, Monoclonal Anitbodies |
| Employees | 51-100 |
| Socials |
Key Contacts at Acumen Pharmaceuticals
Daniel Connell
Chief Executive Officer
Katie Rink
Senior Director, Human Resources
David Potter
Director, Data Management
Istvan Zatik
Medical Director
Kathy Lee
Sr. Director, Cmc Regulatory Affairs
Grant Krafft
Co-Founder And Scientific Advisor
Karima Bettayeb
Medical And Medical Affairs Director
Jen Puhlhorn
Associate Director, Cmc Project Management
Prajakta Dinesh Mangeshkar
Associate Director Of Clinical Operations
Amber Dilley
Sr. Quality Director
Acumen Pharmaceuticals Email Formats
Acumen Pharmaceuticals uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@acumenpharm.com), used 75.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@acumenpharm.com | 75.9% |
{first name}{last name} | johndoe@acumenpharm.com | 20.4% |
{last name}{first initial} | doej@acumenpharm.com | 1.9% |
{last name}{last name} | doedoe@acumenpharm.com | 1.9% |
About Acumen Pharmaceuticals
Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic soluble amyloid-beta oligomers. Our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (Aβo) in synaptic dysfunction and neurodegeneration. These early insights have fostered decades of research on the biology of Aβo at Acumen and throughout the field. We are now on the on cusp of realizing the therapeutic potential of Aβo targeted drugs.
Acumen Pharmaceuticals revenue & valuation
| Annual revenue | $1,436,000 |
| Revenue per employee | $23,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,600,000 |
| Total funding | $50,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Acumen Pharmaceuticals has 35 employees across 12 departments.
Departments
Number of employees
Acumen Pharmaceuticals Tech Stack
Discover the technologies and tools that power Acumen Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Video players
Form builders
Analytics
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Webmail
Miscellaneous
Programming languages
Blogs
Frequently asked questions
4.8
40,000 users



